Noninvasive Ventilation Weaning Protocol in COPD

NCT ID: NCT07133711

Last Updated: 2025-08-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-08-01

Study Completion Date

2025-04-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Noninvasive ventilation (NIV) has revolutionized the management of patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) with hypercapnic respiratory failure (HcRF). NIV use has been shown to reduce the need for endotracheal intubation, hospital and intensive care unit (ICU) length of stay, and mortality.

Multiple studies have been conducted on weaning strategies among patients requiring invasive mechanical ventilation. As a result of these studies, definite criteria and protocols have been laid down for weaning from invasive mechanical ventilation. However, no such data are available for the withdrawal of NIV.

Evidence-based reviews suggest that protocols to manage the weaning and liberation of subjects from Mechanical Ventilation could reduce the time that subjects spend receiving mechanical ventilation. However, no such data about protocolized withdrawal of NIV are available.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A study to compare protocolized weaning from non-invasive ventilation using three potential strategies of weaning from NIV

* Stepwise reduction of duration of NIV use,
* Stepwise reduction in pressure support of NIV, and
* Immediate withdrawal of NIV. Among patients with Acute respiratory failure due to acute exacerbation of COPD.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Obstructive Pulmonary Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Each participant is assigned to only one of the three intervention groups (gradual pressure support decrement, gradual time spent on noninvasive per day decrement, abrupt withdrawal of noninvasive ventilatory support) for the entire duration of the weaning period.
Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors
Due to the nature of the interventions, participants and clinical staff managing the weaning will not be blinded to group assignment. However, outcome assessors \[the physician adjudicating weaning success based on predefined criteria\] and data analysts will be blinded to group allocation throughout the outcome assessment and analysis phases

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Gradual PS Decrement

): pressure support will be reduced by 2-4 cm H2O every 6-8 h with vitals and blood gas monitoring till IPAP of \<8 cm of H2O and EPAP of \<4 cm of H2O is attained, after which NIV will be completely withdrawn

Group Type EXPERIMENTAL

Noninvasive ventilation

Intervention Type DEVICE

Weaning from noninvasive ventilation for patients with acute exacerbation of COPD

Gradual Time Decrement

the duration of NIV will be reduced to 16 h on the day of randomization (day 0), then reduced to 12 h on day 1 (including 6-8 h of overnight use), 6-8 h of overnight use on day 2, and complete withdrawal on day 3.

Group Type EXPERIMENTAL

Noninvasive ventilation

Intervention Type DEVICE

Weaning from noninvasive ventilation for patients with acute exacerbation of COPD

Abrupt Withdrawal

patients will be immediately withdrawn from NIV and monitored on spontaneous breathing.

Group Type ACTIVE_COMPARATOR

Noninvasive ventilation

Intervention Type DEVICE

Weaning from noninvasive ventilation for patients with acute exacerbation of COPD

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Noninvasive ventilation

Weaning from noninvasive ventilation for patients with acute exacerbation of COPD

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All COPD patients admitted in the respiratory ICU with acute Hypercapnic Respiratory Failure who will be managed with Noninvasive Ventilation without the need for invasive mechanical ventilation will be eligible for inclusion in the study.

Exclusion Criteria

* Age: less than 18 years,
* End organ failure as cardiac/ Liver/ Renal,
* Patients on home NIV and
* Those who required NIV for respiratory failure due to diseases other than COPD were not considered for the study.
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Assiut University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Waleed Gamal Elddin Khaleel

Assistant professor of chest diseases

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

waleed gamal elddin, ass. prof

Role: PRINCIPAL_INVESTIGATOR

Assiut University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Assiut University hospital

Asyut, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

References

Explore related publications, articles, or registry entries linked to this study.

Davidson AC, Banham S, Elliott M, Kennedy D, Gelder C, Glossop A, Church AC, Creagh-Brown B, Dodd JW, Felton T, Foex B, Mansfield L, McDonnell L, Parker R, Patterson CM, Sovani M, Thomas L; BTS Standards of Care Committee Member, British Thoracic Society/Intensive Care Society Acute Hypercapnic Respiratory Failure Guideline Development Group, On behalf of the British Thoracic Society Standards of Care Committee. BTS/ICS guideline for the ventilatory management of acute hypercapnic respiratory failure in adults. Thorax. 2016 Apr;71 Suppl 2:ii1-35. doi: 10.1136/thoraxjnl-2015-208209. No abstract available.

Reference Type BACKGROUND
PMID: 26976648 (View on PubMed)

Lun CT, Chan VL, Leung WS, Cheung AP, Cheng SL, Tsui MS, Chu CM. A pilot randomized study comparing two methods of non-invasive ventilation withdrawal after acute respiratory failure in chronic obstructive pulmonary disease. Respirology. 2013 Jul;18(5):814-9. doi: 10.1111/resp.12080.

Reference Type BACKGROUND
PMID: 23490403 (View on PubMed)

Brochard L, Rauss A, Benito S, Conti G, Mancebo J, Rekik N, Gasparetto A, Lemaire F. Comparison of three methods of gradual withdrawal from ventilatory support during weaning from mechanical ventilation. Am J Respir Crit Care Med. 1994 Oct;150(4):896-903. doi: 10.1164/ajrccm.150.4.7921460.

Reference Type BACKGROUND
PMID: 7921460 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

WGEK-NIV-Weaning-Trial

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

NIV for COPD: Hospital to Home
NCT04413643 TERMINATED NA